Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Allen Roses Discusses Ability of GWAS to
Detect ADRs; GSK’s Abacavir is First Up

[March 26, 2008]

Roses, one of the study’s authors and the former head of genetics research at GlaxoSmithKline, discusses what GSK’s genome-wide screening study with abacavir means for the design and conduct of future studies trying to determine the appropriate patient population for a drug before it hits the market.

Login | Subscribe